Conference Paper: Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year

File Download

No File Attached
The HKU Scholars Hub has contact details for these author(s).
- Professor Lai, Ching Lung

Links for fulltext
(May Require Subscription)

Find via

Supplementary

Citations:
- Scopus:
- Web of Science:
- PubMed Central:
Item Statistics (The Hub)
Appears in Collections:
- Medicine: Conference papers

Title	Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
Authors	Gane, E Lai, CL Liaw, YF Thongsawat, S Wang, YM Cheng, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N
Issue Date	2006
Publisher	Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation	Journal of Hepatology, v. 44 n. Suppl 2, p. S183-184 [How to Cite?]
ISSN	0168-8278 2011 Impact Factor: 9.264 2011 SCImago Journal Rankings: 0.765

DC Field	Value
dc.contributor.author	Gane, E
dc.contributor.author	Lai, CL
dc.contributor.author	Liaw, YF
dc.contributor.author	Thongsawat, S
dc.contributor.author	Wang, YM
dc.contributor.author	Cheng, Y
dc.contributor.author	Heathcote, J
dc.contributor.author	Rasenack, J
dc.contributor.author	Bzowej, N
dc.contributor.author	Naoumov, N
dc.contributor.author	Chao, G
dc.contributor.author	Fielman, B
dc.contributor.author	Brown, N
dc.date.accessioned	2010-09-25T20:37:56Z
dc.date.available	2010-09-25T20:37:56Z
dc.date.issued	2006
dc.identifier.citation	Journal of Hepatology, v. 44 n. Suppl 2, p. S183-184 [How to Cite?]
dc.identifier.epage	184
dc.identifier.hkuros	122318
dc.identifier.issn	0168-8278 2011 Impact Factor: 9.264 2011 SCImago Journal Rankings: 0.765
dc.identifier.issue	Suppl 2
dc.identifier.openurl
dc.identifier.spage	183
dc.identifier.uri	http://hdl.handle.net/10722/102618
dc.identifier.volume	, v. 44 n. Suppl 2
dc.language	eng
dc.publisher	Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
dc.relation.ispartof	Journal of Hepatology
dc.rights	Journal of Hepatology. Copyright © Elsevier BV.
dc.title	Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
dc.type	Conference_Paper

<?xml encoding="utf-8" version="1.0"?><item><contributor.author>Gane, E</contributor.author><contributor.author>Lai, CL</contributor.author><contributor.author>Liaw, YF</contributor.author><contributor.author>Thongsawat, S</contributor.author><contributor.author>Wang, YM</contributor.author><contributor.author>Cheng, Y</contributor.author><contributor.author>Heathcote, J</contributor.author><contributor.author>Rasenack, J</contributor.author><contributor.author>Bzowej, N</contributor.author><contributor.author>Naoumov, N</contributor.author><contributor.author>Chao, G</contributor.author><contributor.author>Fielman, B</contributor.author><contributor.author>Brown, N</contributor.author><date.accessioned>2010-09-25T20:37:56Z</date.accessioned><date.available>2010-09-25T20:37:56Z</date.available><date.issued>2006</date.issued><identifier.citation>Journal of Hepatology, v. 44  n. Suppl 2, p. S183-184</identifier.citation><identifier.issn>0168-8278</identifier.issn><identifier.uri>http://hdl.handle.net/10722/102618</identifier.uri><language>eng</language><publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/jhep</publisher><relation.ispartof>Journal of Hepatology</relation.ispartof><rights>Journal of Hepatology. Copyright &#169; Elsevier BV.</rights><title>Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year</title><type>Conference_Paper</type><identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0168-8278&amp;volume=44 &amp;issue=Suppl 2&amp;spage=S183&amp;epage=184&amp;date=2006&amp;atitle=Phase+III+comparison+of+telbivudine+vs+lamivudine+in+HBeAg-positive+patients+with+chronic+hepatitis+B:+Efficacy,+safety,+and+predictors+of+response+at+1+year</identifier.openurl><identifier.hkuros>122318</identifier.hkuros><identifier.volume>, v. 44  n. Suppl 2</identifier.volume><identifier.issue>Suppl 2</identifier.issue><identifier.spage>183</identifier.spage><identifier.epage>184</identifier.epage></item>

Conference Paper: Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year

The HKU Scholars Hub has contact details for these author(s).